Adjuvant Systemic Therapy in Breast Cancer: All 3 Major Types

This workshop delves into personalized approaches for major breast cancer types—HR+/HER2-, HER2-positive, and triple-negative. Attendees will explore standard protocols, discuss scenarios encompassing risk assessment, genomic evaluations, and treatment stratification. Topics include optimizing chemotherapy regimens, managing cardiotoxicities, treatment de-escalation, and therapeutic options for residual disease. Special focus will be given to genomic factors, such as BRCA mutations, and...